An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Summary

This is a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 will be administered to normal healthy volunteers (NHV) and to moderate to severe psoriatic patients, both in sequential ascending dose panels.

Timeline

Start

2015-08

Primary completion

2016-03

Completion

2016-03

Drugs

Indications